PHF1 and neoplasm: To determine whether PHF1 is an epigenetic regulator with clinical significance, we firstly conducted the differential analysis in TCGA-LUAD (N = 483) and GSE68465 (N = 443) datasets, where PHF1 was found to be significantly lower in tumor samples than normal tissues (Fig. 1A–B).